top of page


Stem Cell Therapy for Diabetic Kidney Disease: A Phase 2 Trial Worth Watching; But Not Yet Acting On
Andrew Kowalski, MD, FASN A summary and commentary on: Čižman B, Butler EL, Stavas J, et al. A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney Disease. Clin J Am Soc Nephrol. Published January 2, 2026. doi:10.2215/CJN.0000000969 So if you have not heard, there has been some excitement in the world of kidney disease lately! A article came out in 1/2026 discussing a possible, and promising, use of stem cell therapy to address diabetic kidney disea
Andrew Kowalski
1 day ago5 min read


Chronic Kidney Disease and SGLT2 Inhibitors: From Glucose Drugs to Renal Protection Pillars
An updated version from the last post Andrew Kowalski, MD, FASN CKD remains one of the most underdiagnosed and undertreated conditions in modern medicine, affecting more than one in ten adults worldwide and dramatically increasing the risk of cardiovascular disease, kidney failure, and premature death . For decades, our therapeutic approach rested on a familiar foundation, The Big 4: Blood pressure control Renin-angiotensin system blockade Glycemic management in those with d
Andrew Kowalski
Mar 37 min read


Exploring the Benefits of Kerendia (Finerenone) in Treating Chronic Kidney Disease
Andrew Kowalski, MD, FASN Chronic Kidney Disease (CKD) is a serious health condition affecting millions of people worldwide,...
Andrew Kowalski
Nov 11, 20244 min read
Exploring the Potential Benefits of GLP-1 for Chronic Kidney Disease (CKD) Management
Andrew Kowalski, MD, FASN In recent years, there has been a growing interest in the relationship between GLP-1 receptor agonists and...
Andrew Kowalski
Oct 18, 20244 min read


Chronic Kidney Disease (CKD) and Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: A Game Changer in Renal Care
Andrew Kowalski, MD, FASN Chronic Kidney Disease (CKD) is a silent, progressive condition that affects millions of people worldwide. It...
Andrew Kowalski
Oct 18, 20246 min read
bottom of page


